Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
100.00Prev. Close
97.44Volume
0Total traded value
NAUpper Circuit
116.92Lower Circuit
77.96Fundamentals
| Market Cap | ₹105Cr |
| ROE | 24.80% |
| P/E Ratio(TTM) | 11.29 |
| EPS(TTM) | 8.66 |
| P/B Ratio | 2.93 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.33 |
| Book Value | 33.43 |
| Debt to Equity | 0.37 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Astal Laboratories
Astal Laboratories is a newcomer in the pharmaceutical industry, focusing on the production of bulk drugs and essential intermediate chemical compounds. The company's core values are integrity, transparency, and continuous improvement, with an unwavering commitment to quality in all its products. In its first year of bulk drug operations, the company's profit after tax recorded a massive growth of 4670.76%.;
| Parent Organisation | Astal Laboratories |
| BSE Symbol | 512600 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 105.21 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.98 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.27 | ||
| Wockhardt | NA (0.00%) | -154.77 |